Why Are Exosomes Controversial in Aesthetic Medicine?

Exosomes have quickly gained attention in the world of regenerative aesthetics, promoted for their ability to support cellular communication, repair, and skin rejuvenation. But while the promise is alluring, exosomes remain one of the most controversial topics in medical aesthetics today.

Here’s why clinicians should tread carefully, and what you need to know before adding them to your practice.

1. Regulatory Grey Areas

In many regions—including the UK and EU—exosomes exist in a regulatory grey zone. They are not currently classified as medicines, but their method of derivation and biological activity often exceeds that of typical skincare or injectables.

Depending on their source and method of preparation, some exosome products may require regulation as advanced therapy medicinal products (ATMPs). This lack of clarity makes it difficult for clinicians to ensure compliance and fully understand liability, particularly from animal or human-derived exosomes. 

2. Lack of Standardisation

Not all exosomes are created equal. Currently, there is no unified standard across manufacturers for:
- Source material (e.g. plant, mesenchymal stem cells, placental)
- Isolation technique
- Concentration or purity
- Verification of contents

This means that what’s inside the vial can vary widely from brand to brand—and the clinical effects (and safety) may differ just as much.

3. Unclear Clinical Evidence

While exosome therapy is supported by promising preclinical studies, especially in wound healing and tissue repair, peer-reviewed, placebo-controlled human trials in aesthetic applications are limited. This makes it difficult to separate hype from true, reproducible outcomes.

Some products are marketed with bold claims but without robust human evidence, which puts clinicians in a difficult ethical position.

4. Ethical and Source Concerns

Some exosomes are derived from human placental or embryonic tissues. While often donated and processed ethically, the lack of transparency from certain suppliers raises questions about donor consent, ethical harvesting, and traceability.

Clinicians and patients alike are beginning to demand clearer sourcing policies, especially when products involve biologics.

5. Safety, Storage, and Use Protocols

Because exosomes are biologically active, proper handling and storage are critical. If compromised, the product may lose its efficacy or introduce risk.

Conclusion: Proceed With Informed Caution

Exosomes offer exciting potential in aesthetic medicine, but their integration into clinical practice must be guided by caution, ethics, and a commitment to evidence-based care. From sourcing and storage to regulatory compliance and patient safety, the unknowns still outweigh the knowns in many commercially available products. At Harley Supplies, we’ve taken the time to evaluate the science, question the sourcing, and vet every exosome-based product we offer — because responsible innovation starts with informed, ethical choices.